License and Supply Agreement with Thermo Fisher Scientific signed at Macrogen headquarters Further development of the global CES market expected by expanding Macrogen’s “Genome Supermarket” strategy Kap-Seok Yang, CEO of Macrogen (KOSDAQ: 038290), announced on January 13 that the company has signed a strategic License and Supply Agreement with Thermo Fisher Scientific. The agreement, which was recently […]
Latest chemistry retains the Q50 accuracy of R10 and provides increased throughput and capture, better raw read accuracy and compatibility with PromethION. Designed to improve on R10, which has recently reported at 99.995% single molecule consensus accuracy with UMI method. Flow cells using the latest nanopore chemistry, R10.3, are now available to purchase in the […]
Fluidigm microfluidics technology to fuel growth in genomics services SOUTH SAN FRANCISCO, Calif. — MOgene, a leading provider of genomic and bioinformatic services in St. Louis, today announced it has selected Fluidigm’s (NASDAQ:FLDM) Advanta™ assays and microfluidics-based Juno™ system to expand its next-generation sequencing (NGS) services portfolio. Using Fluidigm’s recently released Advanta RNA-Seq NGS Library […]
DUBLIN, Ireland: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, today announced the signing of a license agreement with Daiichi Sankyo, a global pharmaceutical company with corporate origins in Japan. The agreement provides Daiichi Sankyo with access to CRISPR/Cas9 genome editing technology […]
— Bill Banyai, Ph.D., to Lead DNA Data Storage and Technology Development — SAN FRANCISCO–Jan. 13, 2020– Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the promotion of Patrick Weiss to chief operating officer and the appointment of Bill Banyai, Ph.D., as […]
SAN FRANCISCO, CA – MGI, one of the world’s leading manufacturers of DNA sequencing instruments, today launched its One Million Genomes Total Solution, a full-process software and hardware solution for one million genome projects. The integrated system will promote standardization and effectively solve the pain points in the industry and accelerate the arrival of the […]
CAMBRIDGE, UK, and LEUVEN, Belgium – EVONETIX LTD (‘Evonetix’), the synthetic biology company developing a desktop platform for scalable, high-fidelity and rapid gene synthesis, today announced it has partnered with imec, a world-leading research and innovation hub active in the fields of nanoelectronics and digital technologies, to increase production of Evonetix’s proprietary microelectromechanical systems (MEMS)-based silicon chips, […]
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, and Roche, a global pioneer in pharmaceuticals and diagnostics, today announced a 15-year, non-exclusive collaboration agreement to broaden the adoption of distributable next-generation sequencing-based (NGS) testing in oncology. As the understanding of genomic drivers of cancer evolves, NGS has […]
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) further demonstrated its commitment to making genomics more accessible for the potential benefit of patients today with a series of technology and partnership announcements that further the company’s commitment to unlocking the power of the genome. The NextSeq 2000 Sequencing System — The latest NGS system from Illumina […]
First Company Developing a KRAS(G12C) Inhibitor to Announce Multi-Platform Companion Diagnostics Collaborations With Guardant Health and QIAGEN Will Develop Blood- and Tissue-Based Companion Diagnostics For Investigational KRAS(G12C) Inhibitor AMG 510 KRAS G12C is Present in 13% of Non-Small Cell Lung Cancers With no Approved Targeted Treatments THOUSAND OAKS, Calif. — Amgen (NASDAQ: AMGN) today announced […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
